BioNTech SE (BNTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BNTX.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
BNTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BNTX as an investment opportunity.
- The upside potential (average analyst target price relative to current price) of BNTX is greater than 2.91% of all US stocks.
- BNTX has a less variance in analysts' estimates than 2.84999999999999% of stocks in the large market cap category.
- BioNTech SE's average analyst price target is greater than 89.65% of Pharmaceutical Products stocks.
- BioNTech SE's percent of analysts bearish on the stock is less than 13.1% of Pharmaceutical Products stocks.
- BNTX has a greater number of analysts covering the stock than 14.82% of stocks in the large market cap category.
- BioNTech SE's percentage of analysts bullish on the stock is higher than 20.46% of Pharmaceutical Products stocks.
- BioNTech SE's change in bullishness amongst analysts is lower than almost 100% of all US stocks.
What is the outlook for BNTX? Use POWR Ratings for clearer insight into price direction.